3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Motor Activity
4
Prostatic Neoplasms
3
Malnutrition
3
Stomach Neoplasms
2
Frailty
2
Breast Neoplasms
2
Urologic Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Obesity
1
Neoplasms
1
Hematologic Neoplasms
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Depression
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Alcohol Drinking
1
Interventions
Cyclophosphamide
72
fludarabine
65
Tacrolimus
43
fludarabine phosphate
40
Whole-Body Irradiation
37
Mycophenolic Acid
35
Busulfan
32
Melphalan
28
Antilymphocyte Serum
23
thymoglobulin
22
Thiotepa
20
Methotrexate
20
Standard of Care
19
Stem Cell Transplantation
17
Practice Guidelines as Topic
17
Granulocyte Colony-Stimulating Factor
17
Rituximab
15
Surveys and Questionnaires
12
Sirolimus
12
Filgrastim
12
Interviews as Topic
11
Cyclosporine
11
Blood Specimen Collection
11
Peripheral Blood Stem Cell Transplantation
10
Exercise
10
venetoclax
9
Mesna
9
Cytarabine
9
Bortezomib
9
Hematopoietic Stem Cell Transplantation
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hematologic Neoplasms
×
Nutritional Support
×
Clear all
NCT04057443
2019-08-30
ICOSENIORHEM
L'Hospitalet de Llobregat
Phase NA
Unknown
80 enrolled